Global Aseptic Sampling Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

The Global Aseptic Sampling Market is Segmented by Type of Sampling (Manual Aseptic Sampling (Bags, Bottles and Others) and Automated Aseptic Sampling), Application (Upstream Process and Downstream Process), End-User (Biotechnology and Pharmaceutical Manufacturers, Contract Research and Manufacturing Organizations and Others), and Geography. (North America, Europe, Asia-Pacific, Middle East and Africa and South America). The report offers the value (in USD million) for the above segments.

Market Snapshot

Aseptic Sampling Market
Study Period: 2018 - 2026
Base Year: 2020
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 13.6 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The aseptic sampling market is registered a CAGR of nearly 10.24% during the forecast period. The major factors attributing to the growth of the aseptic sampling market are the rise in the demand for biopharmaceuticals which resulted in the increased adoption of single-use aseptic sampling products.

Movover, owing to the COVID 19 situation, there were many of the companies focused on the development of the effective vaccines, biologics and drugs to prevent/cure the disease. This is increased demand for aseptic testing. However, due to the slow down of development and manufacturing of other pharmaceuticals or biologics coupled with supply chain disruption, the market has witnessed difficulties in 2020.

On the other hand, with growing spending on healthcare and drug development by companies and governments all over the world, aseptic sampling is projected to grow notably over the period. According to the United States Food and Drug Administration, there were about 53 novel drugs approved in 2020 compared to 48 in 2019. Moreover, as per 10th march 2021, there were additional 12 novel drugs approved in United States. In additionas a result of the increase in government expenditure for healthcare, government regulations to ensure drug safety, R&D activities in the segment increase globally, fueling the aseptic sampling market.

Scope of the Report

As per the scope of the report, aseptic sampling is a sterile method of collecting a sample that is implemented during biopharmaceutical processes, to avoid probable contaminations or alterations, while sampling the drug for research and analysis. The market is segmented by type of sampling, application and end-user. By Type of Sampling, market is segmented into Manual Aseptic Sampling and Automated Aseptic Sampling. By Application, market is segmented into
Upstream Process and Downstream Process. By End-User market is segmented into
Biotechnology and Pharmaceutical Manufacturers, Contract Research and Manufacturing Organizations and Others. By Geography, the market is segmented into North America, Europe, Asia-Pacific, Middle East and Africa and South America. The report offers the value (in USD million) for the above segments.

By Type of Sampling
Manual Aseptic Sampling
Bags
Bottles
Others
Automated Aseptic Sampling
Application
Upstream Process
Downstream Process
End-User
Biotechnology and Pharmaceutical Manufacturers
Contract Research and Manufacturing Organizations
Others
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa
GCC
South Africa
Rest of Middle-East and Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Biotechnology and Pharmaceutical Manufacturers Expected to Have Notable growth

In the aseptic sampling market, biotechnology and pharmaceutical manufacturers are expected to have notable growth owing to the growing R&D spending, growing biological and pharmaceutical pipeline. According to the Pharmaceutical Research and Manufacturers of America 2020, in 2019, PhrMA company members have invested about USD 83 billion in worldwide R&D compared to compared to 79.6 billion in 2019. Similarly, according to the European Federation of Pharmaceutical Industries and Associations 2018, In 2017, there an estimated 35,200 million was spent on Pharmaceutical R&D in Europe. Furthermore, these are expected to increase further over the forecast period.

Also, advancements in product technologies and adoption by the pharma and biotech companies are expected to fuel the segment growth. For instance, in May 2020, Aventor Inc has launched OmniTop Sample Tubes Adjustable sampling system for designed specifically for the lower contamination risk and routine sampling in bioprocessing operations. 

Also, with the COVID 19 situation, the manufacturing of essential drugs has been increased tremendously in the majority of the countries in Europe and Asia. The countries around the world are focusing on strengthening the increasing the manufacturing capacity locally and strengthening it requirements on quality of the pharma and biotech procuducts, which is likely to fuel the market growth for aseptic sampling over the period.

Aseptic-sampling-market Share

North America Projected to Have Significant Share Over the Forecast Period.

North America projected to have a notable share of the aseptic sampling market and expected to do the same in the forecast period. Also, the increase in government expenditure for the healthcare sector, early product launches, and stringent government regulations regarding the safety and quality of various drugs will drive the North American aseptic sampling market.

The United States expected to have a significant share owing to the presence of key market players and rising support of the government on production and quality of pharma and biotech products. According to the Organisation for Economic Co-operation and Development (OECD) statistics 2020, in 2018, United States biotechnology companies has spent around 14.9% of the business expenditure of biotechnology. Whereas, Canada has spent only 3.6%.

The Asia Pacific aseptic sampling market is anticipated to show the highest growth rate in throughout the forecast period, owing to large-scale investments made by the key players. Furthermore, the increasing research activities in developing countries, such as China and India will give rise to advanced technological equipment and sampling techniques which boost the market growth in the region.

Global Aseptic Sampling Market - Growth Rate by Region - Image

Competitive Landscape

The aseptic sampling market is moderately competitive and consists of several major players. Some of the market players operating in the market include GEA Group, Gemu Group, Gore & Associates, Keofitt A/S, Lonza Group, Merck KGaA, Qualitru Sampling Systems, Saint Gobain, Sartorius Stedim Biotech and Thermo Fisher Scientific among others. Some prominent players are acquiring the products, entering into partnerships with other companies to consolidate their market positions across the globe and while others are distributing products. For instance, in June 2017, Aseptic Technologies and  MedCision LLC the world leader in next-generation automated cell thawing for advanced therapies has collaborated to expand the integration of Aseptic’s AT-Closed Vials for sample storage with specially designed versions of MedCision’s ThawSTAR therapeutic cell thawing system.

Recent Developments

  • In December 2020, Spartech has acquired Tufpak, Inc., a manufacturer of medical grade engineered films and plastics including biopharmaceutical aseptic sampling bags to expand its market position.
  • In June 2020, ABC Transfer, manufacturer of secure Rapid Transfer Systems (RTS) for sampling in biopharmaceutical industry, has raised EUR 3 million in a series A financing round.

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Stringent Government Regulations for Ensuring Drug Safety

      2. 4.2.2 Increasing Demand for Biopharmaceuticals to Eliminate the Risk of Contamination

    3. 4.3 Market Restraints

      1. 4.3.1 Issues Related to Leachable and Extractables With the Plastic Materials in Sampling Procedure

      2. 4.3.2 Unknown Impurities Generated During the Biopharmaceutical Processes Due to Employment of High Temperatures

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Type of Sampling

      1. 5.1.1 Manual Aseptic Sampling

        1. 5.1.1.1 Bags

        2. 5.1.1.2 Bottles

        3. 5.1.1.3 Others

      2. 5.1.2 Automated Aseptic Sampling

    2. 5.2 Application

      1. 5.2.1 Upstream Process

      2. 5.2.2 Downstream Process

    3. 5.3 End-User

      1. 5.3.1 Biotechnology and Pharmaceutical Manufacturers

      2. 5.3.2 Contract Research and Manufacturing Organizations

      3. 5.3.3 Others

    4. 5.4 Geography

      1. 5.4.1 North America

        1. 5.4.1.1 United States

        2. 5.4.1.2 Canada

        3. 5.4.1.3 Mexico

      2. 5.4.2 Europe

        1. 5.4.2.1 Germany

        2. 5.4.2.2 United Kingdom

        3. 5.4.2.3 France

        4. 5.4.2.4 Italy

        5. 5.4.2.5 Spain

        6. 5.4.2.6 Rest of Europe

      3. 5.4.3 Asia-Pacific

        1. 5.4.3.1 China

        2. 5.4.3.2 Japan

        3. 5.4.3.3 India

        4. 5.4.3.4 Australia

        5. 5.4.3.5 South Korea

        6. 5.4.3.6 Rest of Asia-Pacific

      4. 5.4.4 Middle East and Africa

        1. 5.4.4.1 GCC

        2. 5.4.4.2 South Africa

        3. 5.4.4.3 Rest of Middle-East and Africa

      5. 5.4.5 South America

        1. 5.4.5.1 Brazil

        2. 5.4.5.2 Argentina

        3. 5.4.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Merck KGaA

      2. 6.1.2 Sartorius Stedim Biotech

      3. 6.1.3 Keofitt A/S

      4. 6.1.4 Saint Gobain

      5. 6.1.5 GEA Group

      6. 6.1.6 Qualitru Sampling Systems

      7. 6.1.7 Thermo Fisher Scientific

      8. 6.1.8 Gemu Group

      9. 6.1.9 Gore & Associates

      10. 6.1.10 Lonza Group

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Global Aseptic Sampling Market market is studied from 2018 - 2026.

The Global Aseptic Sampling Market is growing at a CAGR of 13.6% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2020.

Sartorius Stedim Biotech, KEOFITT A/S, Saint Gobain, GEA Group, Merck KGaA are the major companies operating in Global Aseptic Sampling Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!